DXCM — DexCom Inc. stock price and chart

DXCM

DexCom Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq-100 0.1% · Nasdaq Composite 0.06% · S&P 500 0.04% · Russell 1000 0.04% · US Stock Market 0.04% · Russell 3000 0.04% · MSCI World 0.03% · MSCI ACWI 0.02%

$83.03-1.75%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeS

20162019202120242026

20.040.060.080.0100.0120.0140.0160.00100.0M200.0M$83.03

2026-09-11

Price$83.03

MA20$73.16

MA50$71.88

Vol22.4M

What would $1,000 invested in DXCM be worth today? →

DXCM returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $83.03
Change YTD: +25.10%
Next earnings: Oct 29, 2026
Market cap: 31.3B2016-09 7.4B2026-09 31.3B+323.0% over the window
Enterprise value: 30.4B
Shares outstanding: 377.4M2016-06 335.5M2026-06 377.4M+12.5% over the window
52W low: $54.11
52W high: $92.59
From 52W high: -10.33%
From 52W low: +53.45%
52W range: 75%
Beta: 1.42

Volume

Rel volume: 0.52×
30D volume: 4.7M
30D $ vol: 414M

Fundamentals

Sales (ttm): 5B2016-06 489.5M2026-06 5B+915.2% over the window
Sales/share: $13.172016-06 $1.462026-06 $13.17+802.6% over the window
EPS (ttm): $2.512016-06 -$0.242026-06 $2.51-1146.0% over the window
FCF (ttm): 1.4B2016-06 8.1M2026-06 1.4B+17245.7% over the window
FCF/share: $3.722016-06 $0.022026-06 $3.72+15323.1% over the window
Book value/share: $6.952016-06 $0.732026-06 $6.95+846.0% over the window
Net margin: 20.12%2016-06 -16.4%2026-06 20.1%-222.5% over the window
ROE: 38.14%2016-06 -32.6%2026-06 38.1%-216.9% over the window
ROA: 15.49%2016-06 -24.2%2026-06 15.5%-164.1% over the window
Current ratio: 1.732016-06 3.262026-06 1.73-46.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +15.55%2025-06-30 → 2026-06-304.3B → 5B (+15.5% total)+15.83%2023-06-30 → 2026-06-303.2B → 5B (+55.4% total)+18.03%2021-06-30 → 2026-06-302.2B → 5B (+129.0% total)+26.09%2016-06-30 → 2026-06-30489.5M → 5B (+915.2% total)
Net income: +74.99%2025-06-30 → 2026-06-30571.5M → 999.7M (+74.9% total)+40.87%2023-06-30 → 2026-06-30357.5M → 999.7M (+179.6% total)+10.08%2021-06-30 → 2026-06-30618.4M → 999.7M (+61.7% total)n/a
FCF: +146.30%2025-06-30 → 2026-06-30570.8M → 1.4B (+146.1% total)+44.45%2023-06-30 → 2026-06-30466M → 1.4B (+201.5% total)+69.49%2021-06-30 → 2026-06-30100.5M → 1.4B (+1298.0% total)+67.47%2016-06-30 → 2026-06-308.1M → 1.4B (+17245.7% total)
Shares: -3.78%2025-06-30 → 2026-06-30392.2M → 377.4M (-3.8% total)-0.91%2023-06-30 → 2026-06-30387.9M → 377.4M (-2.7% total)-0.50%2021-06-30 → 2026-06-30387M → 377.4M (-2.5% total)+1.18%2016-06-30 → 2026-06-30335.5M → 377.4M (+12.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +79.68%2025-06-30 → 2026-06-30$1.40 → $2.51 (+79.6% total)+44.10%2023-06-30 → 2026-06-30$0.84 → $2.51 (+199.3% total)+12.37%2021-06-30 → 2026-06-30$1.40 → $2.51 (+79.2% total)n/a
Sales/share: +20.09%2025-06-30 → 2026-06-30$10.97 → $13.17 (+20.1% total)+16.89%2023-06-30 → 2026-06-30$8.24 → $13.17 (+59.7% total)+18.62%2021-06-30 → 2026-06-30$5.61 → $13.17 (+134.9% total)+24.61%2016-06-30 → 2026-06-30$1.46 → $13.17 (+802.6% total)
FCF/share: +155.96%2025-06-30 → 2026-06-30$1.46 → $3.72 (+155.8% total)+45.78%2023-06-30 → 2026-06-30$1.20 → $3.72 (+209.9% total)+70.34%2021-06-30 → 2026-06-30$0.26 → $3.72 (+1333.7% total)+65.52%2016-06-30 → 2026-06-30$0.02 → $3.72 (+15323.1% total)
Book value/share: +5.88%2025-06-30 → 2026-06-30$6.56 → $6.95 (+5.9% total)+8.65%2023-06-30 → 2026-06-30$5.42 → $6.95 (+28.3% total)+8.91%2021-06-30 → 2026-06-30$4.53 → $6.95 (+53.2% total)+25.20%2016-06-30 → 2026-06-30$0.73 → $6.95 (+846.0% total)
Price: +9.26%2025-09-11 → 2026-09-11$76.00 → $83.03 (+9.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-8.19%2023-09-11 → 2026-09-11$107.29 → $83.03 (-22.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-9.57%2021-09-10 → 2026-09-11$137.35 → $83.03 (-39.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.57%2016-09-09 → 2026-09-11$23.24 → $83.03 (+257.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +9.26%2025-09-11 → 2026-09-11$76.00 → $83.03 (+9.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-8.19%2023-09-11 → 2026-09-11$107.29 → $83.03 (-22.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-9.57%2021-09-10 → 2026-09-11$137.35 → $83.03 (-39.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.57%2016-09-09 → 2026-09-11$23.24 → $83.03 (+257.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 33.0×2016-09 -130.682026-09 31.35-124.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 27.5×2016-09 -131.842026-09 27.51-120.9% over the window
Fwd P/E: 27.1×
P/S (ttm)Market cap ÷ TTM revenue.: 6.3×2016-09 13.902026-09 6.31-54.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 12.0×2016-09 28.302026-09 11.96-57.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 22.3×2016-09 1646.532026-09 22.31-98.6% over the window
EV/EBITDA (fy): 21.7×
EV/Sales (ttm): 6.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.48%2016-06 0.1%2026-06 5.4%+4872.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 377.4M ÷ 392.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.78%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.78%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($34.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.78%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.1B) ÷ today's market cap ($31.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 3.44%2016-06 -0.2%2026-06 4.2%-2387.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.1B + TTM dividends $0) ÷ today's market cap ($31.3B). Same caveat as the cash buyback yield.: 3.44%2016-06 -0.2%2026-06 4.2%-2387.1% over the window

Vs own 10Y history

P/E: 6th
P/OI: 5th
P/S: 10th
P/B: 14th
P/FCF: 4th

Bar = where today’s multiple sits in DXCM’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-1.75%

-7.45%

-8.56%

+10.34%

YTD

+25.10%

+9.25%

-38.46%

Financial statements

Open full DXCM financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

DexCom Inc. (DXCM) trades at $83.03 with a live price and an interactive chart covering 21+ years of daily price history, plus key valuation metrics. ChartRow also publishes DXCM’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DXCM financial statements →

DXCM — DexCom Inc. price, chart and key statistics